|Inulin (Code C61506)|
|Terms & Properties|
Preferred Name: Inulin
Definition: A naturally occurring, indigestible and non-absorbable oligosaccharide produced by certain plants with prebiotic and potential anticancer activity. Inulin stimulates the growth of beneficial bacteria in the colon, including Bifidobacteria and Lactobacilli, thereby modulating the composition of microflora. This creates an environment that protects against pathogens, toxins and carcinogens, which can cause inflammation and cancer. In addition, fermentation of inulin leads to an increase in short-chain fatty acids and lactic acid production, thereby reducing colonic pH, which may further control pathogenic bacteria growth and may contribute to inulin's cancer protective properties.
CRCH Definition: Class of oligosaccharides produced by plants that are polymers mainly comprised of fructose (generally 2 to 140) units usually with a glucose end. These units are joined by beta-(2-1) glycosidic links.
NCI Metathesaurus Link: C0021936 (see NCI Metathesaurus info)
Synonyms & Abbreviations: (see Synonym Details)
External Source Codes:
|CAS Registry Number||9005-80-5 (see NLM ChemIDplus info)|
|FDA UNII Code||JOS53KRJ01|
|ChEBI ID||CHEBI:15443 (see ChEBI info)|
|PDQ Closed Trial Search ID||486745|
|PDQ Open Trial Search ID||486745 (check for NCI PDQ open clinical trial info)|
|Name||Value (qualifiers indented underneath)|
Additional Concept Data:
|Defined Fully by Roles: No|